On-resin synthesis of novel arginine-isostere peptides bearing substituted amidine headgroups

Journal of Peptide Science

Volumn 18, Issue 1, 2012, Pages 30-36

  Flemer Jr , Stevenson ^a   Madalengoitia, José S ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Amidine; Arginine; Arginine analogs; Combinatorial chemistry; Solid phase synthesis

Indexed keywords

AMIDINE; ARGININE; GUANIDINE; RESIN; THIOAMIDE; TRIFLUOROMETHANESULFONIC ACID;

AMIDINYLATION; AMINO ACID SUBSTITUTION; AMINO ACID SYNTHESIS; ARTICLE; CELL DIVISION; CHEMICAL REACTION; MUKAIYAMA REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; SOLID PHASE SYNTHESIS;

AMIDINES; ARGININE; BIOLOGICAL AGENTS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GUANIDINE; MESYLATES; PEPTIDES; RESINS, SYNTHETIC; SOLID-PHASE SYNTHESIS TECHNIQUES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STEREOISOMERISM; THIOAMIDES; TRIFLUOROACETIC ACID; TRIMETHYLSILYL COMPOUNDS;

EID: 84355166583     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1412     Document Type: Article

References (36)

1. Luhder F, Lee DH, Gold R, Stegbauer J, Linker RA. Small but powerful: short peptide hormones and their role in autoimmune inflammation. J. Immunol. 2009; 217: 1-7.
2. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem. J. 1994; 298: 249-258.
3. Kloss A, Henklein P, Siele D, Schmolke M, Apcher S, Kuehn L, Sheppard PW, Dahlmann B. The cell-penetrating peptide octa-arginine is a potent inhibitor of proteasome activities. Eur. J. Pharm. Biopharm. 2009; 72: 219-225.
4. Stewart KM, Horton KL, Kelley SO. Cell-penetrating peptides as delivery vehicles for biology and medicine. Org. Biomol. Chem. 2008; 6: 2242-2255.
5. Zhang R, Nickl CK, Mamai A, Flemer S, Natarajan A, Dostmann WR, Madalengoitia JS. Poly-L-proline Type II peptide mimics as probes of the active site occupancy requirements of cGMP-dependent protein kinase. J. Pept. Res. 2005; 66: 151-159.
6. Marletta MA. Approaches toward selective inhibition of nitric oxide synthase. J. Med. Chem. 1994; 37: 1899-1907.
7. Peterlin-Mašič L, Kikelj D. Arginine mimetics. Tetrahedron 2001; 57: 7073-7105.
8. Peterlin-Mašič L. Arginine mimetic structures in biologically acive antagonists and inhibitors. Current Med. Chem. 2006; 13: 3627-3648.
9. α methylated carboxylic acids: isosteres of arginine and lysine for use as N-terminal capping residues in polypeptides. Tetrahedron Lett. 2005; 46: 7007-7009.
10. Jensen CM, Lindsay KB, Andreasen P, Skrydstrup T. Synthesis of a hydroxyethylene isostere of the tripeptide Arg-Gly-Leu via a convergent acyl-like radical addition Strategy. J. Org. Chem. 2005; 70: 7512-7519.
11. Mamai A, Hughes NE, Wurthmann A, Madalengoitia JS. Synthesis of conformationally constrained arginine and ornithine analogues based on the 3-Substituted pyrrolidine framework. J. Org. Chem. 2001, 66, 6483-6486.
12. + by arginine analogs that inhibit nitric oxide synthase. Biochim. Biophys. Acta 1997; 1324: 133-141.
13. Rewinkle JBM, Adang AEP. Strategies and progress towards the ideal orally active thrombin inhibitor. Curr. Pharm. Des. 1999; 5: 1043-1072.
14. St. Laurent DR, Balasubramanian N, Han WT, Trehan A, Federici ME, Meanwell NA, Wright JJ, Seiler SM. Active site-directed thrombin inhibitors-II. Studies related to arginine/guanidine bioisosteres. Bioorg. Med. Chem. 1995; 3: 1145-1156.
15. Ewing WR, Becker MR, Manetta VE, Davis RS, Pauls HW, Mason H, Choi-Sledeski YM, Green D, Cha D, Spada AP, Cheney DL, Mason JS, Maignan S, Guilloteau JP, Brown K, Collusi D, Bentley I, Bostwick J, Kasiewski CJ, Morgan SR, Leadly RJ, Dunnwiddie CT, Perrone MH, Chu V. Sulfonamidopyrrolidinone factor Xa inhibitors: potency and selectivity enhancements via P-1 and P-4 optimization. J. Med. Chem. 1999; 42: 3572-3587.
16. Flemer Jr S, Madalengoitia JS. Synthetic routes to N-Pmc-N′, N''-disubstituted guanidines via EDCI-mediated guanylation of amines with N-Pmc-N'-substituted thioureas. Synthesis 2007; 12: 1848-1860.
17. Flemer S, Wurthmann A, Mamai A, Madalengoitia JS. Strategies for the solid-phase diversification of poly-L-proline-Type II peptide mimic scaffolds and peptide scaffolds through guanidinylation. J. Org. Chem. 2008; 73: 7593-7602.
18. Li J, Zhang G, Zhang Z, Fan E. TFA-sensitive arylsulfonylthiourea-assisted synthesis of N, N'-substituted guanidines. J. Org. Chem. 2003; 68: 1611-1614.
19. G-substituted L-arginine analogues suitable for solid phase peptide synthesis. J. Org. Chem. 2008; 73: 7849-7851.
20. η-substituted arginyl peptide inhibitors of protein arginine N-methyltransferases. ACS Chem. Biol. 2010; 5: 1053-1063.
21. 2+-arginase by borate leads to the design of a transition state analog inhibitor, 2(S)-amino-6-boronohexanoic acid. J. Am. Chem. Soc. 1997; 119: 8107-8108.
22. de Marco R, di Goya ML, Leggio A, Liguori A, Perri F, Siciliano C, Viscomi MC. A new non-natural arginine-ike amino acid derivative with a sulfamoyl group in the side chain. Amino Acids 2010; 38: 691-700.
23. 6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. J. Med. Chem. 1994; 37: 3886-3888.
24. Eustache J, Grob A, Lam C, Sellier O, Schulz G. Conformationally constrained NO synthase inhibitors: rigid analogs of L-N-iminoethylornithine. Bioorg. Med. Chem. Lett. 1998; 8: 2961-2966.
25. Hallinan EA, Tsymbalov S, Finnegan PM, Moore WM, Jerome GM, Currie MG, Pitzele BS. Acetamidine lysine derivative, N-(5(S)-amino-6, 7-dihydroxyheptyl)-ethanimidamide dihydrochloride: a highly selective inhibitor of human inducible nitric oxide synthase. J. Med. Chem. 1998; 41: 775-777.
26. dos Santos MS, Bernardino AMR, de Souza MC. Principais métodos de síntese de amidinas. Quim. Nova 2006; 29: 1301-1306.
27. Dunn PJ. Amidines and N-substituted amidines; from Comprehensive Functional Group Transformations II, Katritzky AR, Taylor RJK (eds). Elsevier: Amsterdam, 2005: 655-699.
28. Kent DR, Cody WL, Doherty AM. The asymmetric synthesis of arginine mimetics: derivatives of (S)-2-, 3- and 4-amidinophenylalanine suitable for incorporation into enzyme inhibitors and/or peptides. J. Pept. Res. 1998; 52: 201-207.
29. Sturzebecher J, Prasa D, Hauptmann J, Vieweg H, Wikstrom P. Synthesis and structure-activity relationships of potent thrombin inhibitors: piperazides of 3-amidinophenylalanine. J. Med. Chem. 1997; 40: 3091-3099.
30. 5-(1-imino-3-butenyl)-L-ornithine: a neuronal isoform selective mechanism-based inactivator of nitric oxide synthase. J. Biol. Chem. 1998; 273: 8882-8889.
31. Wang Y, Monzingo AF, Hu S, Schaller TH, Robertus JD, Fast W. Developing dual and specific inhibitors of dimethylarginine dimethylaminohydrolase-1 and nitric oxide synthase: toward a targeted polypharmacology to control nitric oxide. Biochemistry, 2009; 48: 8624-8635.
32. Flemer S, Madalengoitia JS. A comprehensive and facile entry into substituted amidines via the condensation of N-Pmc-substituted thioamides with amines using Mukaiyama reagent as a thiophile. Synthesis, 2011; 10: 1638-1648.
33. Walter W, Röhr A. Über die struktur der thioamide und ihrer derivate, XXX: N-sulfonylthioamide. Liebigs Ann. Chem. 1975: 41-53.
34. Veenstra JA. Isolation and structure of corazonin, a cardioactive peptide from the American cockroach. FEBS Lett. 1989; 250: 231-234.
35. Story SC, Aldrich JV. Side-product formation during cyclization with HBTU on a solid support. Int. J. Pept. Protein Res. 1994; 43: 292-296.
36. Basso N, Terragno NA. History about the discovery of the renin-angiotensin system. Hypertension 2001; 38: 1246-1249.